Highest-materiality recent filing
Xylem appoints Andrea van der Berg CFO; Grogan departs Aug 31; reaffirms 2026 guidance
William K. Grogan resigns as EVP & CFO effective Aug 31, 2026, to pursue another opportunity; stays through Sep 13.
Xylem appoints D. Christian Koch to board; board expands to 10 directors
D. Christian Koch appointed to Xylem board effective Aug 13, 2026; board size increased from 9 to 10.
Xylem Q2 orders surge 42% to $3.1B; raises full-year adjusted EPS guidance to $5.55-$5.70
Revenue $2.3B (+2% reported, +1% organic); GAAP EPS $1.11 (+19%), adjusted EPS $1.46 (+16%).
Xylem issues $1B in senior notes: $500M at 5.200% due 2033, $500M at 5.450% due 2036
$500M 5.200% Senior Notes due June 1, 2033; $500M 5.450% Senior Blue Notes due June 1, 2036.
Xylem shareholders elect nine directors, ratify auditor, approve advisory compensation and ESPP
All nine director nominees elected with at least 84.6% of votes cast; Jerome Peribere received 20.75M against.
Xylem Q1 adjusted EPS $1.12 (+9%), revenue $2.1B (+3%); FY guidance raised
Q1 orders $2.2B (+3% reported, flat organic); revenue $2.1B (+3% reported).
Xylem Board authorizes $1.5B share repurchase program with no expiration
New share repurchase program authorizes up to $1.5 billion in common stock purchases.
Xylem Q4 adjusted EPS $1.42 (+20% YoY), full-year revenue $9.0B record; dividend raised 8%
Q4 revenue $2.4B (+6% reported, +4% organic); orders $2.4B (+9%, +7% organic).
Xylem Q3 2025: revenue up 8% to $2.3B; adj. EPS $1.37, +23%; raises full-year guidance
Revenue $2.3B, +8% reported (+7% organic); net income $227M ($0.93 EPS).
Xylem Q2 revenue $2.3B (+6% organic); EPS $0.93; adj. EPS $1.26; raises FY guidance
Revenue $2.3B, up 6% reported and organic; net income $226M ($0.93/share), up 16%.
All nine director nominees elected: Earl R. Ellis, Robert F. Friel, Lisa Glatch, Victoria D. Harker, Mark D. Morelli, Jerome A. Peribere, Matthew F. Pine, Lila Tretikov, Uday Yadav.
Xylem Q1 revenue $2.1B, adj EPS $1.03, beats expectations; reaffirms FY guidance
Revenue $2.1B, up 2% reported and 3% organic; book-to-bill ratio above 1.0.
Xylem beats Q4 guidance; revenue $2.3B, adj. EPS $1.18; raises dividend 11%
Q4 revenue $2.3B, up 7% organic; orders $2.2B, up 7%; GAAP EPS $1.34 (+22%), adjusted EPS $1.18 (+19%).
Xylem confirms FY2024 results in-line/above guidance; announces restructuring with $95-115M charges
On Jan 28, 2025, management committed to a restructuring plan with workforce reductions across all businesses.
Xylem director Jeanne Beliveau-Dunn to not seek re-election at 2025 annual meeting
Jeanne Beliveau-Dunn informed Board on Jan 10, 2025 of her decision not to stand for re-election.
Xylem Q3 revenue $2.1B, adjusted EPS $1.11 (+12% YoY); narrows FY guidance
Revenue $2.1B, up 1% reported and organic; orders up 8%.
Xylem appoints Meredith Emmerich as Applied Water President; Cerwinka steps down
Franz Cerwinka steps down as SVP & President, Applied Water effective Oct 21; advisor until March 31, 2025.
Xylem Q2 revenue $2.2B (+26% reported, +9% organic); EPS $0.80, adj EPS $1.09; raises FY guidance
Net income $194M ($0.80 EPS), up 78%; adjusted EPS $1.09, up 11%.
Xylem shareholders elect all 10 directors, approve say-on-pay and auditor at 2024 annual meeting
All 10 director nominees elected, with support ranging from 88.4% to 95.0% of votes cast (excluding broker non-votes).
Xylem beats Q1 estimates, raises FY revenue and adjusted EPS guidance
Q1 revenue of $2.0B (+40% reported, +7% organic); orders $2.2B (+43% reported, +3% organic).
Xylem recasts 2021-2023 segment data after creating Water Solutions & Services segment
Recast shows 2023 revenue of $7,364M; Water Solutions & Services contributed $1,684M.
Q4 orders $2.0B (+42% reported, +10% organic); revenue $2.1B (+41% reported, +9% organic).
Xylem creates Water Solutions and Services segment effective Jan 1, 2024
New WSS segment unifies legacy Evoqua ISS with Xylem dewatering and assessment services.
Xylem Q3 revenue $2.1B (+50% reported, +10% organic); raises FY guidance
Revenue $2.1B, up 50% reported, 10% organic; orders up 43% reported, 3% organic.
Patrick Decker retires as CEO effective Dec 31, 2023; will serve as senior advisor through March 31, 2024.
Xylem Q2 revenue up 26% to $1.7B, adjusted EPS $0.98; raises FY guidance
Revenue $1.7B, up 26% reported and 15% organic; net income $92M, GAAP EPS $0.45.
Xylem completes Evoqua acquisition; files Evoqua FY2022 financials: rev $1.74B, net $72.3M
Merger closed May 24, 2023; Evoqua historical financials filed in 8-K/A amendment.
Xylem Q2 revenue $1.7B (+26% reported, +15% organic); raises FY guidance
GAAP EPS $0.45 (down 27%); adjusted EPS $0.98 (up 32%).
Each Evoqua share converted into 0.48 Xylem share; Xylem holders own ~75%, Evoqua ~25% fully diluted.
Xylem shareholders approve share issuance for Evoqua merger; closing awaits China clearance
Shareholders voted 145.6M FOR, 585K AGAINST, 1.4M abstentions on share issuance proposal.
Xylem Q1 revenue $1.4B (+14%), adj. EPS $0.72 (+53%); raises full-year guidance
Revenue $1.4B, up 14% reported and 17% organically; GAAP EPS $0.54, adjusted EPS $0.72.
Xylem upsizes revolving credit facility to $1B, appoints ABM CFO to board
New $1B senior unsecured revolving credit facility (can increase to $1.3B) replaces prior $800M facility.
Xylem CEO Decker enters 10b5-1 plan to sell up to 255,595 shares over 12 months
Plan dated Feb 10, 2023; sales may occur Mar 13, 2023 to Feb 9, 2024 at market prices.
Xylem Q4 revenue $1.5B (+14%), adj EPS $0.92 (+46%); guides FY23 adj EPS $3.00-$3.25
Q4 revenue $1.5B (+14% reported, +20% organic); adj EPS $0.92 (+46% vs prior year).
Xylem to acquire Evoqua in $7.5B all-stock deal; 0.48 exchange ratio, ~29% premium
Enterprise value ~$7.5B; Evoqua shareholders receive 0.48 Xylem shares per share, valued at ~$52.89, a 29% premium.
Xylem appoints Matthew Pine as COO effective Jan 1, 2023; drives operational excellence
Matthew Pine appointed COO effective Jan 1, 2023; will oversee all three business segments and regions.
Xylem adopts Fifth Amended and Restated By-laws with updated shareholder nomination procedures
Board approved new By-laws effective Nov 10, 2022; updates procedural mechanics for shareholder proposals and director nominations.
Xylem to redeem entire €500M 2.250% Senior Notes due 2023 on Dec 12, 2022
Redemption of €500M aggregate outstanding principal amount of 2.250% Senior Notes due 2023.
Xylem Q3 revenue $1.4B, adj EPS $0.79; raises FY2022 revenue and EPS guidance
Q3 revenue $1.4B, +9% reported, +16% organic; net income $12M/$0.07 GAAP EPS due to pension settlement.
Xylem Q2 revenue $1.4B, EPS $0.62 (adj $0.66); raises FY organic revenue guidance to 8-10%
Revenue $1.4B, +1% reported (+6% organic); net income $112M ($0.62 EPS); adj EPS $0.66.
Xylem shareholders elect all ten director nominees and ratify auditor at annual meeting
Ten directors elected at May 12, 2022 Annual Meeting; Victoria D. Harker received highest against votes (25M), still elected.
Director Jorge M. Gomez resigns from Xylem board; no disagreement
Jorge M. Gomez resigned as director effective May 11, 2022.
Xylem Q1 rev $1.3B, EPS $0.45; raises FY22 organic rev guide to 4-6%, adj EPS $2.40-2.70
Q1 revenue $1.3B, up 4% organically; organic orders +14%, record backlog.
Xylem reports FY2021 rev $5.2B (+7%), adj EPS $2.49 (+21%); guides FY22 adj EPS $2.35-$2.70
Q4 revenue $1.32B; Q4 adj EPS $0.63; FY net income $427M, adj net income $452M.
Xylem Q3 revenue $1.27B (+2% organic); cuts FY guidance on supply chain issues
Q3 reported EPS $0.63, adjusted EPS $0.63; revenue $1.27B (+4% reported, +2% organic).
Xylem Q2 revenue $1.35B (+16% reported); raises FY organic growth guidance to 6-8%
Net income $113M ($0.62 EPS); adjusted EPS $0.66; revenue up 11% organically vs prior year.
On January 10, 2025, Jeanne Beliveau-Dunn informed the Board of Directors (the “Board”) of Xylem Inc. (the “Company”) of her decision not to stand for re-election as a Director of the Company at the Company’s 2025 annual meeting of shareholders (“2025 Annual Meeting”).
Effective October 21, 2024, Franz W. Cerwinka will cease to serve as Xylem Inc.’s (the “Company”) Senior Vice President and President, Applied Water and Xylem Business Transformation.
Xylem's Board appointed Mattew F. Pine, age 52, as the Company's President and Chief Executive Officer to succeed Mr. Decker and to serve as a member of the Board, effective January 1, 2024.
Patrick K. Decker will retire from his position as President and Chief Executive Officer and resign from the Board of Directors ("Board") effective December 31, 2023
Effective October 1, 2023, Sandra E. Rowland will cease to serve as Senior Vice Preside
appointed Lisa Glatch and Lynn C. Swann as members of the Board to fill the resulting vacancies.
appointed Lisa Glatch and Lynn C. Swann as members of the Board to fill the resulting vacancies.
On February 24, 2023, the Board of Directors (the “Board”) of the Company increased the size of the Board from 10 to 11 directors, and appointed Earl R. Ellis as a member of the Board to fill the vacancy, effective March 9, 2023.
On December 19, 2022, the Board of Directors (“Board”) of Xylem Inc. (the “Company”) appointed Matthew F. Pine as the Company’s Chief Operating Officer, effective January 1, 2023.
Effective May 11, 2022, Jorge M. Gomez resigned as a director of Xylem Inc.
On May 2, 2022, the Board of Directors (“Board”) of Xylem Inc. (“Xylem” or “Company”) appointed Matthew F. Pine to the office of Senior Vice President and President, Americas, Applied Water Systems and Measurement and Controls Solutions effective May 4, 2022.
Colin Sabol stepped down from his position with Xylem as Senior Vice President and President, Measurement and Control Solutions.
Max materiality 0.85 · Median 0.72 · Most common event earnings